Class information for:
Level 1: LITHIUM AUGMENTATION//RESISTANT DEPRESSION//DEP S CLIN PROGRAM

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
6290 1439 42.1 71%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
667 12573 ANTIDEPRESSANTS//AGOMELATINE//MOCLOBEMIDE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LITHIUM AUGMENTATION Author keyword 36 79% 2% 23
2 RESISTANT DEPRESSION Author keyword 25 52% 2% 34
3 DEP S CLIN PROGRAM Address 23 23% 6% 88
4 TREATMENT RESISTANT DEPRESSION Author keyword 22 22% 6% 85
5 EPIDEMIOL DATA Address 17 27% 4% 53
6 REFRACTORY DEPRESSION Author keyword 15 40% 2% 29
7 EXTENDED RELEASE QUETIAPINE FUMARATE Author keyword 7 57% 1% 8
8 ANXIOUS DEPRESSION Author keyword 7 32% 1% 17
9 COMBINATION ANTIDEPRESSANTS Author keyword 6 71% 0% 5
10 MOOD DISORDERS PROGRAM CLIN Address 6 47% 1% 9

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 LITHIUM AUGMENTATION 36 79% 2% 23 Search LITHIUM+AUGMENTATION Search LITHIUM+AUGMENTATION
2 RESISTANT DEPRESSION 25 52% 2% 34 Search RESISTANT+DEPRESSION Search RESISTANT+DEPRESSION
3 TREATMENT RESISTANT DEPRESSION 22 22% 6% 85 Search TREATMENT+RESISTANT+DEPRESSION Search TREATMENT+RESISTANT+DEPRESSION
4 REFRACTORY DEPRESSION 15 40% 2% 29 Search REFRACTORY+DEPRESSION Search REFRACTORY+DEPRESSION
5 EXTENDED RELEASE QUETIAPINE FUMARATE 7 57% 1% 8 Search EXTENDED+RELEASE+QUETIAPINE+FUMARATE Search EXTENDED+RELEASE+QUETIAPINE+FUMARATE
6 ANXIOUS DEPRESSION 7 32% 1% 17 Search ANXIOUS+DEPRESSION Search ANXIOUS+DEPRESSION
7 COMBINATION ANTIDEPRESSANTS 6 71% 0% 5 Search COMBINATION+ANTIDEPRESSANTS Search COMBINATION+ANTIDEPRESSANTS
8 EARLY IMPROVEMENT 5 38% 1% 11 Search EARLY+IMPROVEMENT Search EARLY+IMPROVEMENT
9 TREATMENT REFRACTORY DEPRESSION 3 39% 0% 7 Search TREATMENT+REFRACTORY+DEPRESSION Search TREATMENT+REFRACTORY+DEPRESSION
10 ANTIDEPRESSANT SWITCH 3 100% 0% 3 Search ANTIDEPRESSANT+SWITCH Search ANTIDEPRESSANT+SWITCH

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 REFRACTORY DEPRESSION 96 45% 11% 159
2 STAR ASTERISK D 85 29% 18% 254
3 TREATMENT REFRACTORY DEPRESSION 60 72% 3% 48
4 LITHIUM AUGMENTATION 53 55% 5% 67
5 SEQUENCED TREATMENT ALTERNATIVES 40 42% 5% 74
6 REPORT QIDS SR 39 38% 6% 80
7 TREATMENT RESISTANT DEPRESSION 33 14% 15% 215
8 TRIIODOTHYRONINE AUGMENTATION 31 61% 2% 33
9 QUICK INVENTORY 31 34% 5% 73
10 TRUE DRUG RESPONSE 30 56% 3% 36

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials 2009 184 25 84%
If at First You Don't Succeed A Review of the Evidence for Antidepressant Augmentation, Combination and Switching Strategies 2011 67 73 74%
Comparative Efficacy, Acceptability, and Tolerability of Augmentation Agents in Treatment-Resistant Depression: Systematic Review and Network Meta-Analysis 2015 3 77 69%
Risk factors for treatment resistance in unipolar depression: A systematic review 2015 5 29 28%
Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach 2014 12 40 40%
Augmentation with Atypical Antipsychotics for Depression: A Review of Evidence-Based Support from the Medical Literature 2013 14 49 82%
A systematic review and meta-analysis of the evidence base for add-on treatment for patients with major depressive disorder who have not responded to antidepressant treatment: A European perspective 2014 8 30 53%
Treatment-resistant depression: therapeutic trends, challenges, and future directions 2012 23 105 55%
Staging methods for treatment resistant depression. A systematic review 2012 24 59 53%
Role of Lithium Augmentation in the Management of Major Depressive Disorder 2014 8 80 46%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DEP S CLIN PROGRAM 23 23% 6.1% 88
2 EPIDEMIOL DATA 17 27% 3.7% 53
3 MOOD DISORDERS PROGRAM CLIN 6 47% 0.6% 9
4 NOTTINGHAM PSYCHOTHER Y UNIT 4 75% 0.2% 3
5 PSYCHIATDEP S CLIN PROGRAM 3 30% 0.5% 7
6 CLIN PSYCHOPHARMACOL UNIT 2 10% 1.5% 22
7 CNS GLOBAL MED AFFAIRS 2 67% 0.1% 2
8 CTNI 2 67% 0.1% 2
9 FIELD MED AFFAIRS 2 67% 0.1% 2
10 GEN PRACTICE PRIMARY CARE GRP 2 50% 0.2% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000220803 VENLAFAXINE//MILNACIPRAN//ESCITALOPRAM
2 0.0000211984 CHRONIC DEPRESSION//DYSTHYMIA//CBASP
3 0.0000181923 MAJOR DEPRESSION INVENTORY//FREDERIKSBORG GEN HOSP//MELANCHOLIA SCALE
4 0.0000160993 ACCELERATED RESPONSE//BODILY SENSATION//CARE TEAM
5 0.0000154993 MOCLOBEMIDE//ATYPICAL DEPRESSION//BROFAROMINE
6 0.0000150158 DELUSIONAL DEPRESSION//PSYCHOTIC DEPRESSION//PSYCHOTIC MAJOR DEPRESSION
7 0.0000137266 MIRTAZAPINE//ORG 3770//C 11MIRTAZAPINE
8 0.0000133233 PINDOLOL//VILAZODONE//NEUROBIOL PSYCHIAT UNIT
9 0.0000109973 NORFLUOXETINE//FLUVOXAMINE//CITALOPRAM
10 0.0000104267 AGOMELATINE//MELATONERGIC RECEPTORS//S 20098